River BioMedics

About:

River BioMedics is a biotech company that aims to develop human 3D in vitro 3D human heart tissue for pre-clinical drug testing.

Website: https://riverbiomedics.com/

Top Investors: BioGeneration Ventures, OostNL, KIKK Capital

Description:

River BioMedics is a biotech company that aims to develop human 3D in vitro 3D human heart tissue for pre-clinical drug testing. Currently pharmaceutical companies spend a billion dollar figure on the development of a new drug entity, with a 90% chance of it failing to reach the market. The most common reason for failure during this developmental stage is drug induced cardiac toxicity. To solve this issue we develop 3D cardiac tissues, resembling the working human heart, for advanced drug discovery and toxicity screening using a multidisciplinary human stem cell-based approach.

Total Funding Amount:

1.8M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Enschede, Overijssel, The Netherlands

Founded Date:

2018-01-01

Contact Email:

marcelo.ribeiro(AT)riverbiomedics.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2022-01-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai